TrialJournal of the European Academy of Dermatology and Venereology : JEADV2026

Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis.

Melinda Gooderham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.